Event
Microsure raises €38 million Series B2 to advance MUSA-3 microsurgical robot
Key points
- Microsure closed a €38 million Series B2 financing round to advance development of its MUSA-3 microsurgical robot.
- The company said the funding would support final development, clinical studies, FDA clearance work in the United States, and CE mark preparation in Europe.
- Investors included the European Innovation Council Fund, kineo finance, Invest-NL, Innovation Industries, Brabantse Ontwikkelings Maatschappij, TCIM, Eindhoven University of Technology, and Venturing Tech.
Company context
Microsure is a Dutch medical robotics company developing robot-assisted systems for open microsurgery and supermicrosurgery. Its MUSA platform is designed to let surgeons perform high-precision procedures using scaled, tremor-filtered joystick control while retaining their own microsurgical instruments through disposable adapters.
Context
- Company
- Microsure
- Segment
- Healthcare
- Event type
- Funding
- Geography
- Eindhoven · Netherlands